Pt(<scp>ii</scp>) and Pt(<scp>iv</scp>) complexes with a major component of royal jelly as innovative antitumor drug candidates-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pt(ii) and Pt(iv) complexes with a major component of royal jelly as innovative antitumor drug candidates

Published:2023 Issue:39 Volume:47 Page:18386-18399
ISSN:1144-0546
Container-title:New Journal of Chemistry
language:en
Short-container-title:New J. Chem.

Author:

Barbanente Alessandra¹,Gandin Valentina²,Donati Chiara²,Pierro Carmela Ilaria¹,Natile Giovanni¹,Margiotta Nicola¹^ORCID

Affiliation:

1. Dipartimento di Chimica, Università degli Studi di Bari Aldo Moro, Via E. Orabona 4, 70125 Bari, Italy

2. Dipartimento di Scienze del Farmaco, Università di Padova, Via Marzolo 5, 35131 Padova, Italy

Abstract

The major and unique fatty acid in Royal Jelly, trans-10-hydroxy-2-decenoic acid, which have anti-tumor, immunomodulatory, and other properties, has been combined with the antitumor platinum moiety of clinically used oxaliplatin.

Funder

Universita degli Studi di Bari Aldo Moro

Publisher

Royal Society of Chemistry (RSC)

Subject

Materials Chemistry,General Chemistry,Catalysis

Link

http://pubs.rsc.org/en/content/articlepdf/2023/NJ/D3NJ03617K

Reference48 articles.

1. Metallodrugs are unique: opportunities and challenges of discovery and development

2. Antitumour metal compounds: more than theme and variations

3. Inhibition of transcription by platinum antitumor compounds

4. Platinum(iv) anticancer prodrugs – hypotheses and facts

5. Platinum Complexes as Anticancer Agents

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP